Delivery Order SPE2DB20D3303-SPE2DB25FA1VK
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $13,846.97 to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsule unit dose packages (30-count) with an ultimate completion date of August 8, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation, to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Vyndamax (tafamidis) is a transthyretin stabilizer used to treat transthyretin amyloid cardiomyopathy,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Vyndamax 61 mg capsule unit dose packaging in quantities of 30, valued at $13,846.97. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitive award to the prime contractor. The contract is set for ultimate completion by August 14, 2025, with performance based at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $13,846.97 on July 28, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages (30-count) with a completion deadline of August 18, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $13,846.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Vyndamax 61 mg capsules in unit-dose packaging (30-count). The contract, with an ultimate completion date of August 12, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This competitively...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages (30-count). This order, valued at $13,846.97 with a firm fixed price structure, represents a non-competitive, non-set-aside procurement issued under a delivery order contract type and is scheduled for completion by August 18, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $13,846.97 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages in quantities of 30. The contract utilizes firm fixed pricing with an ultimate completion date of August 8, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same municipality. This...
- The Defense Logistics Agency awarded a $13,846.97 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for Vyndamax 61 mg capsule unit dose 30-count packages. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of August 8, 2025, and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting open competition among qualified vendors. This delivery...
- The Defense Logistics Agency awarded a $13,846.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Vyndamax 61 mg capsules (unit dose, 30-count packages) with an ultimate completion date of August 8, 2025. The contract, issued on July 18, 2025, is unclassified and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a $27,693.94 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for supply of Vyndamax 61 mg capsule unit dose packages in quantities of 30. This non-set-aside award was competitively procured and is scheduled for completion by August 12, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a discrete task order issued under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $13,846.97 for Vyndamax 61 mg capsule unit dose 30-count packages under a firm fixed price contract. The award was made on July 23, 2025, with an ultimate completion date of August 13, 2025, with performance at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded without set-aside designation and represents a routine pharmaceutical...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA1VKDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages in quantities of 30, with a ceiling value of $13,846.97. This is a firm fixed price delivery order with no set-aside designation, reflecting competitive award criteria. The contract is set to complete by August 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Vyndamax (tafamidis) is a disease-modifying transthyretin stabilizer used primarily in the treatment of transthyretin amyloidosis, indicating this delivery supports specialized pharmaceutical needs within the military healthcare system. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.999 billion prime vendor agreement running through December 2026 that provides comprehensive global pharmaceutical support to military health programs. As a leading pharmaceutical distributor, AmerisourceBergen Drug Corp maintains an extensive portfolio of federal medical supply contracts with the Defense Logistics Agency and serves multiple government healthcare systems including the Defense Health Agency and U.S. Coast Guard. The company's established presence as a prime vendor positions it as a critical supplier for federal medical procurement across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.8k | 7/28/25 |